Uveal Melanoma UK National Guidelines.

[1]  L. Desjardins,et al.  Staging of ciliary body and choroidal melanomas based on anatomic extent. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  J. Testa,et al.  Further evidence for germline BAP1 mutations predisposing to melanoma and malignant mesothelioma. , 2013, Cancer genetics.

[3]  B. Damato,et al.  Molecular pathology of uveal melanoma , 2013, Eye.

[4]  P. Ghaneh,et al.  MRI in the detection of hepatic metastases from high-risk uveal melanoma: a prospective study in 188 patients , 2012, British Journal of Ophthalmology.

[5]  B. Damato,et al.  Detection and time to treatment of uveal melanoma in the United Kingdom: an evaluation of 2,384 patients. , 2012, Ophthalmology.

[6]  A. Eleuteri,et al.  Estimating prognosis for survival after treatment of choroidal melanoma , 2011, Progress in Retinal and Eye Research.

[7]  P. Finger The 7th edition AJCC staging system for eye cancer: an international language for ophthalmic oncology. , 2009, Archives of pathology & laboratory medicine.

[8]  C. Shields,et al.  Metastasis of uveal melanoma millimeter-by-millimeter in 8033 consecutive eyes. , 2009, Archives of ophthalmology.

[9]  D. H. Dinh,et al.  Choroidal nevus transformation into melanoma: analysis of 2514 consecutive cases. , 2009, Archives of ophthalmology.

[10]  J. Augsburger,et al.  Effectiveness of treatments for metastatic uveal melanoma. , 2009, American journal of ophthalmology.

[11]  A. Biggeri,et al.  Survival in patients with uveal melanoma in Europe. , 2008, Archives of ophthalmology.

[12]  W. Rubinstein,et al.  Genetic study of familial uveal melanoma: association of uveal and cutaneous melanoma with cutaneous and ocular nevi. , 2007, Ophthalmology.

[13]  J. Earle,et al.  Development of metastatic disease after enrollment in the COMS trials for treatment of choroidal melanoma: Collaborative Ocular Melanoma Study Group Report No. 26. , 2005, Archives of ophthalmology.

[14]  Ahmedin Jemal,et al.  Incidence of noncutaneous melanomas in the U.S. , 2005, Cancer.

[15]  Arun D. Singh,et al.  Sunlight exposure and pathogenesis of uveal melanoma. , 2004, Survey of ophthalmology.

[16]  M. Saornil Iris colour and uveal melanoma. , 2004, Canadian journal of ophthalmology. Journal canadien d'ophtalmologie.

[17]  T. Kivelä,et al.  Very long-term prognosis of patients with malignant uveal melanoma. , 2003, Investigative ophthalmology & visual science.

[18]  M. Parsons,et al.  Prediction of prognosis in patients with uveal melanoma using fluorescence in situ hybridisation , 2001, The British journal of ophthalmology.

[19]  C. Shields,et al.  Iris melanoma: risk factors for metastasis in 169 consecutive patients. , 2001, Ophthalmology.

[20]  R. Scully,et al.  Assessment of metastatic disease status at death in 435 patients with large choroidal melanoma in the Collaborative Ocular Melanoma Study (COMS): COMS report no. 15. , 2001, Archives of ophthalmology.

[21]  R. Rees,et al.  Association of specific chromosome alterations with tumour phenotype in posterior uveal melanoma , 2000, British Journal of Cancer.

[22]  R. Elston,et al.  Lifetime prevalence of uveal melanoma in white patients with oculo(dermal) melanocytosis. , 1998, Ophthalmology.

[23]  S. Wallace,et al.  The prevalence and location of metastases from ocular melanoma: imaging study in 110 patients. , 1991, AJR. American journal of roentgenology.

[24]  J. Reidy,et al.  Melanocytoma: nomenclature, pathogenesis, natural history and treatment. , 1985, Survey of ophthalmology.

[25]  D. A. BRUNNING,et al.  European Journal of Cancer , 1966, Nature.